Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
C2N Diagnostics
St. Louis, MO, USAc2n.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
The company's flagship blood tests, including PrecivityAD® and PrecivityAD2™, have demonstrated clinical diagnostic performance comparable to gold-standard amyloid PET imaging and CSF biomarkers. These tests are available in the US and select international markets, with over fifteen thousand biomarker measures reported in peer-reviewed publications. Their technology has been used in major clinical trials—including those supporting new Alzheimer’s therapies—and continues to expand globally through partnerships.[3][4][10]
- Therapeutic areas
- Neurology
- Modalities
- Biomarkers (blood-based)Diagnostic assays (mass spectrometry-based)[1][4]
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
Eisai Inc./Co., Ltd. – investment and use of assays in LEQEMBI® clinical trials for Alzheimer's therapy support[3][10].Unilabs – multi-year exclusive partnership to distribute Precivity™ portfolio across Europe, Peru, Saudi Arabia, UAE.[7]National Institute on Aging/National Institutes of Health – research funding/collaboration support [4].Alzheimer's Drug Discovery Foundation – significant funding via Diagnostics Accelerator initiative [7].
Beyond the preview
Go deeper on C2N Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on C2N Diagnostics.